TachoSil Paediatric Liver Trial (TC-019-IN)
NCT00365248
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Liver Diseases
Interventions
DRUG:
Fibrinogen human (TachoSil)
Sponsor
Nycomed